New annual osteoporosis drug reduces risk of death, future fractures.  Infused dose is more convenient for patients, enhances overall quality of life.
D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D006620:Hip Fractures / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008019:Life Style; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid